QIAGEN AARHUS A/S: Financial statements 2012
CVR: 28305087
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
QIAGEN AARHUS A/S (CVR 28305087) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 29,982,000 and a net result of DKK 938,000. Equity in the 2012 report amounted to DKK 21,903,000. The solvency ratio was 30.5%. The company had 87 employees in the financial year.
- Gross Profit
- DKK 29,982,000
- Profit/Loss
- DKK 938,000
- Equity
- DKK 21,903,000
- Total Assets
- DKK 71,906,000
- Employees
- 87
Official annual report
Keep an eye on QIAGEN AARHUS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout QIAGEN AARHUS A/S
QIAGEN AARHUS A/S is a Danish company of the type Aktieselskab based in Aarhus C, founded in 2004. The company is registered under the industry Computerprogrammering. The company was previously named CLC BIO A/S and GENIEMATICS A/S. The management consists of Jonas Buur Sinding and Timothy Paul Grabham. The board consists of Axel Backheuer (chair), Magnus Fellenius-Blædel, Martin Kofod Ludvigsen and Philipp Sixt Lothar von Hugo. The company is owned by Qiagen N.v.. The company has 57 employees (2026). In 2025, the company reported a gross profit of DKK 83,701,000 and a net result of DKK 4,914,000 compared with DKK 5,867,000 the year before. Equity in the 2025 report amounted to DKK 76,212,000.